Grieve DJ - Search Results

1

Are targeted therapies for diabetic cardiomyopathy on the horizon?

Tate M, Grieve DJ, Ritchie RH. Tate M, et al. Among authors: grieve dj. Clin Sci (Lond). 2017 May 1;131(10):897-915. doi: 10.1042/CS20160491. Clin Sci (Lond). 2017. PMID: 28473471 Review.

2

Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes.

Tate M, Chong A, Robinson E, Green BD, Grieve DJ. Tate M, et al. Among authors: grieve dj. Br J Pharmacol. 2015 Feb;172(3):721-36. doi: 10.1111/bph.12943. Epub 2014 Dec 1. Br J Pharmacol. 2015. PMID: 25231355 Free PMC article. Review.

3

Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix.

Robinson E, Cassidy RS, Tate M, Zhao Y, Lockhart S, Calderwood D, Church R, McGahon MK, Brazil DP, McDermott BJ, Green BD, Grieve DJ. Robinson E, et al. Among authors: grieve dj. Basic Res Cardiol. 2015 Mar;110(2):20. doi: 10.1007/s00395-015-0476-7. Epub 2015 Mar 1. Basic Res Cardiol. 2015. PMID: 25725809 Free PMC article.

4

Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages.

Tate M, Robinson E, Green BD, McDermott BJ, Grieve DJ. Tate M, et al. Among authors: grieve dj. Basic Res Cardiol. 2016 Jan;111(1):1. doi: 10.1007/s00395-015-0518-1. Epub 2015 Nov 23. Basic Res Cardiol. 2016. PMID: 26597728 Free PMC article.

5

Metabolically-inactive glucagon-like peptide-1(9-36)amide confers selective protective actions against post-myocardial infarction remodelling.

Robinson E, Tate M, Lockhart S, McPeake C, O'Neill KM, Edgar KS, Calderwood D, Green BD, McDermott BJ, Grieve DJ. Robinson E, et al. Among authors: grieve dj. Cardiovasc Diabetol. 2016 Apr 14;15:65. doi: 10.1186/s12933-016-0386-5. Cardiovasc Diabetol. 2016. PMID: 27079193 Free PMC article.

6

Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2.

McLaughlin D, Zhao Y, O'Neill KM, Edgar KS, Dunne PD, Kearney AM, Grieve DJ, McDermott BJ. McLaughlin D, et al. Among authors: grieve dj. Br J Pharmacol. 2017 Nov;174(21):3677-3695. doi: 10.1111/bph.13773. Epub 2017 Apr 22. Br J Pharmacol. 2017. PMID: 28261787 Free PMC article.

7

Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.

Wilson AJ, Gill EK, Abudalo RA, Edgar KS, Watson CJ, Grieve DJ. Wilson AJ, et al. Among authors: grieve dj. Heart. 2018 Feb;104(4):293-299. doi: 10.1136/heartjnl-2017-311448. Epub 2017 Sep 27. Heart. 2018. PMID: 28954833 Review.

8

Diabetic Nephropathy: a Tangled Web to Unweave.

Magee C, Grieve DJ, Watson CJ, Brazil DP. Magee C, et al. Among authors: grieve dj. Cardiovasc Drugs Ther. 2017 Dec;31(5-6):579-592. doi: 10.1007/s10557-017-6755-9. Cardiovasc Drugs Ther. 2017. PMID: 28956186 Free PMC article. Review.

9

Methanolic Extract of Phoenix Dactylifera Confers Protection against Experimental Diabetic Cardiomyopathy through Modulation of Glucolipid Metabolism and Cardiac Remodeling.

Nawaz L, Grieve DJ, Muzaffar H, Iftikhar A, Anwar H. Nawaz L, et al. Among authors: grieve dj. Cells. 2024 Jul 15;13(14):1196. doi: 10.3390/cells13141196. Cells. 2024. PMID: 39056777 Free PMC article.

10

Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Cowan E, Burch KJ, Green BD, Grieve DJ. Cowan E, et al. Among authors: grieve dj. Br J Pharmacol. 2016 Jul;173(14):2165-81. doi: 10.1111/bph.13502. Epub 2016 May 27. Br J Pharmacol. 2016. PMID: 27111465 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters